E
ELV
Elevance Health Inc
300.74
+2.24+0.75%After Hours: 301.00 +0.26 +0.09%18:53 04/02 EDT
OPEN/PREV CLOSE295.24/298.50
TODAY RANGE294.89-302.94
VOL1.19M
MARKET CAP66.37B
52 WEEK RANGE269.17-449.16
AVG VOL (3M)1.93M
% TURNOVER0.54%
TURNOVER--
P/E (TTM)11.93
% RANGE2.70%
EPS(TTM)25.21
P/E(FORWARD)12.49
P/B1.513
BVPS198.81
DIVIDEND6.88
P/S0.3334
BETA--
DIV YIELD2.29%
FREE FLOAT MKT CAP66.21B
SHARES OUTSTANDING220.70M
NEXT EARNINGS04/20-04/24
FREE FLOAT220.15M
LOT SIZE1
EX-DATE03/10/2026
News
Press Releases
Financial Reports
Profile
Seeking Alpha·49m ago
Insurers to receive extra $18B as Medicare overhauls Star Ratings system
Simply Wall St·23h ago
Is Elevance Health’s Leadership Realignment Around Medicare And Carelon Reshaping The Investment Case For ELV?
MarketWatch·1d ago
It’s not just patients who are sick of fighting health insurers. Doctors are frustrated, too.
Simply Wall St·4d ago
Is It Time To Reassess Elevance Health (ELV) After A 33% One‑Year Share Price Slide
Dow Jones·4d ago
*Elevance Health: Darrell Oliveira Named CFO for Carelon >ELV
Dow Jones·4d ago
*Elevance Health Aimee Dailey Named Pres of Govt Business >ELV
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.